Chondrosarcoma of the pelvis - case report.

Chondrosarcoma (CHS) is the third most common primary bone tumor after myeloma and osteosarcoma. Histologically, it is made of pure hyaline cartilage differentiation. The tumor itself may have myxoid modification and calcification. It occurs especially after 50 years, with an equal gender distribution. Most CHS are solitary, the etiology is still unclear and most of them are discovered accidentally. Early diagnosis is crucial for a good prognosis. In this paper, we would like to present a case of a female patient with an accidentally discovered CHS of the iliopubic and ischiopubic ramus of the pelvis. The purpose of this report is to highlight the importance of multidisciplinary management of tumor pathology, especially when the site of the tumor is surgically hardly accessible and to underline possible common genetic aspects of benign and malignant tumors.

[1]  Abdel Kareem Azab,et al.  The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy , 2015, Hypoxia.

[2]  V. Jain,et al.  Ollier Disease: Pathogenesis, Diagnosis, and Management. , 2015, Orthopedics.

[3]  R. von Eisenhart-Rothe,et al.  [Primary malignant bone tumors]. , 2011, Der Orthopade.

[4]  S. Fehlberg,et al.  Survival and prognostic factors in chondrosarcoma , 2011, Acta orthopaedica.

[5]  J. Bovée,et al.  Enchondromatosis: insights on the different subtypes. , 2010, International journal of clinical and experimental pathology.

[6]  P. Hogendoorn,et al.  The cytotoxic effect of phenol and ethanol on the chondrosarcoma-derived cell line OUMS-27: an in vitro experiment. , 2008, The Journal of bone and joint surgery. British volume.

[7]  D. Biau,et al.  Dedifferentiated chondrosarcoma: prognostic factors and outcome from a European group. , 2007, European journal of cancer.

[8]  H. Jüppner,et al.  Ollier disease , 2009, Definitions.

[9]  T. Aigner,et al.  Prognostic relevance of cell biologic and biochemical features in conventional chondrosarcomas , 2002, Cancer.

[10]  A. Chott,et al.  Platelet-Derived Growth Factor-&agr; Receptor Expression Supports the Growth of Conventional Chondrosarcoma and Is Associated With Adverse Outcome , 2001, The American journal of surgical pathology.

[11]  A. Cleton-Jansen,et al.  Molecular genetic characterization of both components of a dedifferentiated chondrosarcoma, with implications for its histogenesis , 1999, The Journal of pathology.

[12]  D. Ilstrup,et al.  Primary chondrosarcoma of long bones and limb girdles , 1998, Cancer.

[13]  F. Bertoni,et al.  Classification of bone tumors. , 1998, European journal of radiology.

[14]  B. Coughlan,et al.  p53 expression and DNA ploidy of cartilage lesions. , 1995, Human pathology.

[15]  M. Romsdahl,et al.  Prognostic factors in chondrosarcoma of bone. A clinicopathologic analysis with emphasis on histologic grading , 1977, Cancer.

[16]  Jean Y. J. Wang,et al.  Platelet-Derived Growth Factor C Is Upregulated in Human Uterine Fibroids and Regulates Uterine Smooth Muscle Cell Growth , 2009 .

[17]  K. Weber,et al.  Low-grade/dedifferentiated/high-grade chondrosarcoma: a case of histological and biological progression. , 2002, The Iowa Orthopaedic Journal.

[18]  G. Delling,et al.  [Histologic grading of chondrosarcoma. A qualitative and quantitative analysis of 74 cases of the Hamburg bone tumor register]. , 1996, Der Pathologe.

[19]  H. W. Wouters,et al.  Curettage and acrylic cementation in surgery of giant cell tumors of bone. , 1976, Clinical orthopaedics and related research.

[20]  A. Ketcham,et al.  Maffucci's syndrome: functional and neoplastic significance. Case report and review of the literature. , 1973, The Journal of bone and joint surgery. American volume.